# OnCo record cervavac (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cervavac/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cervavac" ;
  schema:name "CERVAVAC (quadrivalent HPV vaccine, India)"@en ;
  schema:alternateName "qHPV vaccine (Serum Institute)"@en, "Cervavac"@en, "CERVAVAC" ;
  schema:description "India's first home-made HPV vaccine, protecting against the two virus types that cause most cervical cancers and the two that cause genital warts, at a price meant for a national programme."@en ;
  schema:url <https://onco.cc/drugs/cervavac/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.seruminstitute.com/product_ind_cervavac.php>, <https://doi.org/10.1002/cncr.70292>, <https://doi.org/10.3390/vaccines14020140> ;
  onco:status "approved" ;
  onco:modality "Prophylactic vaccine (virus-like particles)" ;
  onco:approval "IN 2022: Prevention of HPV 6/11/16/18-related cancers and genital warts, ages 9-26" ;
  onco:related <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/ideas/idea-single-dose-hpv-self-sampling-elimination/> ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:companies <https://onco.cc/companies/serum-institute-of-india/> ;
  onco:institutions <https://onco.cc/institutions/dbt-india/>, <https://onco.cc/institutions/iarc/> ;
  onco:trials <https://onco.cc/trials/iarc-india-hpv-dose-study/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-prevention-adoption/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-basu-single-dose-hpv-lancet-oncol-2021/>, <https://onco.cc/key-papers/paper-tamrakar-cancer/>, <https://onco.cc/key-papers/paper-akgor-vaccines-basel/> .